Cumberland Pharmaceuticals (CPIX) EBITDA (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted EBITDA of -$3.1 million for Q1 2026, down 128.22% sequentially from -$1.4 million in Q4 2025, and down 342.22% YoY from $1.3 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) EBITDA (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported EBITDA for 17 years, with the latest figure at -$3.1 million in Q1 2026.
- Quarterly EBITDA fell 342.22% year-over-year to -$3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.2 million (down 120.51% YoY) and the FY2025 annual result came in at -$2.8 million, up 56.59% from the prior year.
- EBITDA eased to -$3.1 million in Q1 2026 per CPIX's latest filing, from -$1.4 million in the prior quarter.
- Over five years, EBITDA peaked at $1.3 million in Q1 2025 and troughed at -$6.2 million in Q4 2023.
- A 5-year average of -$1.6 million and a median of -$1.7 million in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2024 and 2025: EBITDA plunged 4591.4% in 2024, then soared 169.12% in 2025.
- Over 5 years, EBITDA stood at -$2.3 million in 2022, then tumbled by 171.28% to -$6.2 million in 2023, then jumped by 70.19% to -$1.8 million in 2024, then climbed by 25.56% to -$1.4 million in 2025, then plunged by 128.22% to -$3.1 million in 2026.
- According to Business Quant data, EBITDA over the past three periods registered -$3.1 million, -$1.4 million, and -$2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.40 Bn | 39.75 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.85 Bn | 30.18 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.68 Bn | 15.29 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.48 Mn | 112.62 Mn | - | -3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.16 Mn |
| Mar 31, 2026 | -3.13 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.97 Mn |
| Jun 30, 2025 | -747,478.00 |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.69 Mn |
| Jun 30, 2024 | -1.03 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Dec 31, 2023 | -6.18 Mn |
| Sep 30, 2023 | -1.87 Mn |
| Jun 30, 2023 | 22,859.00 |
| Mar 31, 2023 | -1.53 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | -288,588.00 |
| Jun 30, 2022 | -1.85 Mn |
| Mar 31, 2022 | -1.29 Mn |
| Dec 31, 2021 | -4.35 Mn |
| Sep 30, 2021 | -1.56 Mn |